Indegene Limited (INDGN.BO)
Indegene Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Bengaluru, KA, IN. The stock last traded at $554.75, down 2.59% on the session, giving a market capitalisation of $133.73B. Its beta of 0.72 implies it has historically moved less than the broad market.
Indegene Limited operates as a global commercialization partner within the life sciences sector. The company assists biopharmaceutical, nascent biotechnology, and medical device organizations throughout their product's journey, from initial development and market introduction to sustained growth and impact. Its comprehensive offerings include a range of enterprise solutions for commercial, medical, and clinical operations, advanced omnichannel activation strategies, and its proprietary NEXT technology platforms. Established in 1998, the company maintains its headquarters in Bengaluru, India.
Indegene Limited is most often compared with the following Healthcare names: